Trials / Recruiting
RecruitingNCT04224389
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
Prospective Non-randomized Comparative Study Between IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas of Early Local Stage of Oropharynx
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compare patients' feelings in terms of swallowing ability assessed by the overall score of MD Anderson Dysphagia Inventory (MDADI) 2 years after starting treatment between patients who have been treated with IMRT and those who were treated by transoral surgery for a squamous cell carcinoma of the early stage oropharynx.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transoral resection | The technique of transoral surgery will be left to the choice of the surgeon according to the equipment and the experience of the team and will be gathered. The options are: transoral surgery robot-assisted, endoscopic laser transoral surgery, transoral laser surgery classical instruments. The exact description of the resected area will be collected. of the cross-sections will be made for extemporaneous analysis if necessary in lateral margins and deep until complete excision. |
| RADIATION | IMRT | Intensity modulation radiotherapy (RCMI or IMRT) will be performed using techniques static or rotational (arctherapy, tomotherapy). Restraint is recommended with thermoformed mask |
Timeline
- Start date
- 2018-06-22
- Primary completion
- 2031-06-01
- Completion
- 2031-06-01
- First posted
- 2020-01-13
- Last updated
- 2025-05-08
Locations
16 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04224389. Inclusion in this directory is not an endorsement.